Dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract cancer - Authors' reply. - Subbiah, Vivek; Lassen, Ulrik; Gasal, Eduard; Burgess, Paul; Wainberg, Zev A (Lancet Oncology, 2020)